vs

Side-by-side financial comparison of Marwynn Holdings, Inc. (MWYN) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

Vivos Therapeutics, Inc. is the larger business by last-quarter revenue ($3.8M vs $2.3M, roughly 1.6× Marwynn Holdings, Inc.). Marwynn Holdings, Inc. runs the higher net margin — -116.0% vs -180.3%, a 64.2% gap on every dollar of revenue. On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -13.3%).

Marwynn Holdings, Inc. is a Canada-based investment holding company focused on acquiring, managing, and scaling middle-market businesses primarily across North America. Its core operating segments cover industrial products, consumer goods, and technology-enabled services, targeting sustainable long-term value creation for its stakeholders.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

MWYN vs VVOS — Head-to-Head

Bigger by revenue
VVOS
VVOS
1.6× larger
VVOS
$3.8M
$2.3M
MWYN
Growing faster (revenue YoY)
VVOS
VVOS
+16.7% gap
VVOS
3.4%
-13.3%
MWYN
Higher net margin
MWYN
MWYN
64.2% more per $
MWYN
-116.0%
-180.3%
VVOS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MWYN
MWYN
VVOS
VVOS
Revenue
$2.3M
$3.8M
Net Profit
$-2.7M
$-6.9M
Gross Margin
42.4%
78.1%
Operating Margin
-115.8%
-166.8%
Net Margin
-116.0%
-180.3%
Revenue YoY
-13.3%
3.4%
Net Profit YoY
-11713.9%
-143.8%
EPS (diluted)
$-0.16
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MWYN
MWYN
VVOS
VVOS
Q4 25
$3.8M
Q3 25
$2.3M
$6.8M
Q2 25
$3.8M
Q1 25
$623.7K
$3.0M
Q4 24
$3.7M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$3.4M
Net Profit
MWYN
MWYN
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$-2.7M
$-5.4M
Q2 25
$-5.0M
Q1 25
$23.4K
$-3.9M
Q4 24
$-2.8M
Q3 24
$-2.6M
Q2 24
$-1.9M
Q1 24
$-3.8M
Gross Margin
MWYN
MWYN
VVOS
VVOS
Q4 25
78.1%
Q3 25
42.4%
58.0%
Q2 25
55.2%
Q1 25
39.2%
50.0%
Q4 24
56.7%
Q3 24
60.5%
Q2 24
65.4%
Q1 24
56.7%
Operating Margin
MWYN
MWYN
VVOS
VVOS
Q4 25
-166.8%
Q3 25
-115.8%
-69.8%
Q2 25
-127.4%
Q1 25
13.5%
-129.9%
Q4 24
-75.9%
Q3 24
-68.5%
Q2 24
-47.8%
Q1 24
-110.7%
Net Margin
MWYN
MWYN
VVOS
VVOS
Q4 25
-180.3%
Q3 25
-116.0%
-79.6%
Q2 25
-131.2%
Q1 25
3.8%
-128.1%
Q4 24
-76.4%
Q3 24
-67.8%
Q2 24
-47.6%
Q1 24
-110.1%
EPS (diluted)
MWYN
MWYN
VVOS
VVOS
Q4 25
$-0.58
Q3 25
$-0.16
$-0.49
Q2 25
$-0.55
Q1 25
$0.00
$-0.45
Q4 24
$0.41
Q3 24
$-0.40
Q2 24
$-0.60
Q1 24
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MWYN
MWYN
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$2.3M
$-1.5M
Total Assets
$11.6M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MWYN
MWYN
VVOS
VVOS
Q4 25
$2.0M
Q3 25
$3.1M
Q2 25
$4.4M
Q1 25
$480
$2.3M
Q4 24
$6.3M
Q3 24
$6.3M
Q2 24
$6.9M
Q1 24
$2.6M
Total Debt
MWYN
MWYN
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
MWYN
MWYN
VVOS
VVOS
Q4 25
$-1.5M
Q3 25
$2.3M
$2.5M
Q2 25
$4.6M
Q1 25
$2.4M
$4.4M
Q4 24
$8.0M
Q3 24
$7.7M
Q2 24
$6.3M
Q1 24
$582.0K
Total Assets
MWYN
MWYN
VVOS
VVOS
Q4 25
$25.2M
Q3 25
$11.6M
$25.6M
Q2 25
$26.0M
Q1 25
$12.6M
$11.3M
Q4 24
$15.3M
Q3 24
$15.3M
Q2 24
$15.8M
Q1 24
$11.8M
Debt / Equity
MWYN
MWYN
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MWYN
MWYN
VVOS
VVOS
Operating Cash FlowLast quarter
$-95.1K
$-3.8M
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-139.7%
Capex IntensityCapex / Revenue
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MWYN
MWYN
VVOS
VVOS
Q4 25
$-3.8M
Q3 25
$-95.1K
$-4.2M
Q2 25
$-3.5M
Q1 25
$-3.8M
Q4 24
$-2.9M
Q3 24
$-4.2M
Q2 24
$-3.0M
Q1 24
$-2.5M
Free Cash Flow
MWYN
MWYN
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$-4.2M
Q2 25
$-4.3M
Q1 25
$-3.9M
Q4 24
$-3.1M
Q3 24
$-4.4M
Q2 24
$-3.1M
Q1 24
$-2.7M
FCF Margin
MWYN
MWYN
VVOS
VVOS
Q4 25
-139.7%
Q3 25
-62.6%
Q2 25
-111.6%
Q1 25
-129.9%
Q4 24
-84.0%
Q3 24
-113.4%
Q2 24
-76.7%
Q1 24
-78.0%
Capex Intensity
MWYN
MWYN
VVOS
VVOS
Q4 25
40.0%
Q3 25
1.2%
Q2 25
20.2%
Q1 25
4.0%
Q4 24
4.5%
Q3 24
5.0%
Q2 24
1.5%
Q1 24
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MWYN
MWYN

Other$1.3M57%
Revenue From Recyclable Ewaste Materials Sales$1.0M43%

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons